These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3618243)

  • 1. [Experimental studies of the combination of vincristine and 1,2:5,6-dianhydrogalactitol].
    Fan YJ; Han R; Zhou J; Li M
    Yao Xue Xue Bao; 1987 Feb; 22(2):98-102. PubMed ID: 3618243
    [No Abstract]   [Full Text] [Related]  

  • 2. Inability of amphotericin B(Fungizone) or of sodium deoxycholate to alter natural drug resistance or sensitivity of transplanted murine leukemias.
    Ganu UK; Khandalekar DD; Gokhale SV
    Indian J Physiol Pharmacol; 1984; 28(1):21-6. PubMed ID: 6490126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.
    Novotny L; Rauko P; Liska J; Elford HL; Szekeres T
    Cancer Lett; 2006 Feb; 233(1):178-84. PubMed ID: 15885888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination vincristine and VP-16-213: evaluation of drug sequence.
    Jackson DV; Long TR; Rice DG; Morgan TM
    Cancer Biochem Biophys; 1986 Oct; 8(4):265-75. PubMed ID: 3802048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
    Góra-Tybor J; Robak T; Warzocha K; Grieb P
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):39-42. PubMed ID: 7503633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J; Robak T
    Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of 1,2:5,6-dianhydrogalactitol in combination with maytansine in experimental tumor therapy].
    Fan YJ; Zhou J; Li M
    Yao Xue Xue Bao; 1983 Sep; 18(9):648-53. PubMed ID: 6677049
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo.
    Razek A; Vietti T; Valeriote F
    Cancer Res; 1974 Aug; 34(8):1857-61. PubMed ID: 4842737
    [No Abstract]   [Full Text] [Related]  

  • 9. Metoclopramide and nitrendipine are unable to enhance cytotoxicity of mitoxantrone in sensitive and resistant murine leukemias in vivo.
    Potemski P; Polakowski P
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):249-53. PubMed ID: 9597095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cure of mice bearing P388 leukemia by vincristine in combination with a calcium channel blocker.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Treat Rep; 1985 May; 69(5):523-5. PubMed ID: 4005874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
    Ninomiya K; Sekido S; Araki T
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1315-23. PubMed ID: 6428326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [L 1210 leukemia, an experimental model for the potentiation of drugs used for acute leukemias].
    Pouillart P; Huong TH; Lhéritier J
    Bull Cancer; 1974; 61(4):509-26. PubMed ID: 4458834
    [No Abstract]   [Full Text] [Related]  

  • 13. Vitamin A: failure to demonstrate in mice an anti-tumour effect, whether combined with cytotoxic drugs or not.
    Cattan A; Bresson ML
    Bull Cancer; 1986; 73(2):201-6. PubMed ID: 3730637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of vincristine on methotrexate uptake by L1210 cells and mouse intestinal epithelia in vitro and in vivo.
    Chello PL; Sirotnak FM; Dorick DM
    Cancer Res; 1979 Jun; 39(6 Pt 1):2106-12. PubMed ID: 445407
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of biological response modifier sulfoethylated (1 --> 3)-beta-D-glycan on the experimental leukemia in mice].
    Khalikova TA; Korolenko TA
    Eksp Klin Farmakol; 2006; 69(5):39-43. PubMed ID: 17153965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias.
    Avery TL; Roberts D
    Cancer Res; 1973 Apr; 33(4):791-9. PubMed ID: 4696479
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia.
    Chello PL; Sirotnak FM
    Cancer Treat Rep; 1981; 65(11-12):1049-53. PubMed ID: 7296551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation by acyclothymidine esters of the antitumor effect of orally administered 5-fluoro-2'-deoxyuridine esters on L1210 in mice.
    Kawaguchi T; Saito M; Saneyoshi M
    Jpn J Cancer Res; 1986 May; 77(5):436-9. PubMed ID: 2942523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone.
    Burns ER; Scheving LE
    Chronobiologia; 1980; 7(1):41-51. PubMed ID: 7438892
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergistic effect of ricin in combination with daunorubicin, cis-dichlorodiammineplatinum(II) and vincristine in systemic L1210 leukemia.
    Fodstad O; Pihl A
    Cancer Res; 1982 Jun; 42(6):2152-8. PubMed ID: 7200398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.